Menu

• Ask a Health Expert about BLOOD UREA DECREASED
• Post Your Side Effect related to BLOOD UREA DECREASED
• BLOOD UREA DECREASED and FDA Warnings
• BLOOD UREA DECREASED in Patients Wiki
• Report BLOOD UREA DECREASED in Drug Side Effect Survey

BLOOD UREA DECREASED side effect

What is BLOOD UREA DECREASED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Vesicare Side Effects Report #5546951-6
Physician from JAPAN reported VESICARE problem on Nov 27, 2007. Female patient, 50 years of age, weighting 100.1 lb, was diagnosed with hypertonic bladder and was treated with VESICARE. After drug was administered, patient experienced the following problems/side effects: blood urea decreased, condition aggravated, gastric cancer, malignant neoplasm progression, . VESICARE dosage: 5 MG, UID/QD, ORAL. During the same period patient was treated with BIO THREELET, RIZE, VOLTMIE. Patient died on 10/11/2007.

Vesicare Side Effects Report #5572490-2
VESICARE problem was reported by a Physician from JAPAN on Dec 11, 2007. Female patient, 50 years of age, weighting 100.1 lb, was diagnosed with hypertonic bladder and was treated with VESICARE. After drug was administered, patient experienced the following problems/side effects: blood urea decreased, gastric cancer, malignant neoplasm progression, . VESICARE dosage: 5 MG, UID/QD, ORAL. During the same period patient was treated with BIO THREELET, RIZE, VOLTMIE. Patient died on 10/11/2007.

Vesicare Side Effects Report #5533929-1
Physician from JAPAN reported VESICARE problem on Nov 13, 2007. Female patient, 50 years of age, weighting 100.1 lb, was diagnosed with hypertonic bladder and was treated with VESICARE. After drug was administered, patient experienced the following problems/side effects: blood urea decreased, condition aggravated, gastric cancer, malignant neoplasm progression, . VESICARE dosage: 5 MG, UID/QD, ORAL. During the same period patient was treated with BIO THREELET, RIZE, VOLTIME. Patient recovered.

Diovan Side Effects Report #5413214-9
DIOVAN problem was reported by a Health Professional from UNITED STATES on Aug 06, 2007. Female patient, 44 years of age, weighting 146.0 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood urea decreased, blood urea nitrogen/creatinine ratio decreased, heart rate increased, hyponatraemia, water intoxication, . DIOVAN dosage: unknown. Patient recovered.


Diovan Side Effects Report #5394962-6
Health Professional from UNITED STATES reported DIOVAN problem on July 19, 2007. Female patient, 44 years of age, weighting 146.0 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood urea decreased, blood urea nitrogen/creatinine ratio decreased, heart rate increased, hyponatraemia, . DIOVAN dosage: unknown. Patient recovered.

Diovan Side Effects Report #5394962-6
DIOVAN problem was reported by a Health Professional from UNITED STATES on July 19, 2007. Female patient, 44 years of age, weighting 146.0 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: blood urea decreased, blood urea nitrogen/creatinine ratio decreased, heart rate increased, hyponatraemia, . DIOVAN dosage: unknown. Patient recovered.

Zometa Side Effects Report #5257079-7
Consumer or non-health professional from UNITED STATES reported ZOMETA problem on Feb 21, 2007. Female patient, 65 years of age, was diagnosed with osteoporosis and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: blood urea decreased, dyskinesia, dyspnoea, feeling abnormal, muscle twitching, pharyngeal oedema, tremor, . ZOMETA dosage: 4 MG EVERY 6 MONTHS. Patient recovered.

Valtrex Side Effects Report #5537397-5
VALTREX problem was reported by a Physician from JAPAN on Nov 30, 2007. Female patient, 64 years of age, weighting 121.3 lb, was diagnosed with herpes zoster and was treated with VALTREX. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, blood urea decreased, creatinine renal clearance increased, renal disorder, . VALTREX dosage: unknown. During the same period patient was treated with VOLTAREN. Patient was hospitalized. Patient recovered.

Carboplatin Side Effects Report #5519484-0
Consumer or non-health professional from UNITED KINGDOM reported CARBOPLATIN problem on Oct 30, 2007. Male patient, 43 years of age, was diagnosed with leiomyosarcoma, hypercalcaemia, prophylaxis and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, blood urea decreased, haemodialysis, renal tubular disorder, tumour lysis syndrome, . CARBOPLATIN dosage: unknown. During the same period patient was treated with ALLOPURINOL, DAUNORUBICIN, HYDROXYUREA. Patient recovered.


Valtrex Side Effects Report #5523358-9
VALTREX problem was reported by a Physician from JAPAN on Nov 16, 2007. Female patient, 64 years of age, weighting 121.3 lb, was diagnosed with herpes zoster and was treated with VALTREX. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, blood urea decreased, creatinine renal clearance increased, renal disorder, . VALTREX dosage: unknown. During the same period patient was treated with VOLTAREN. Patient was hospitalized. Patient recovered.

Tekturna Side Effects Report #5488109-5
Physician from UNITED STATES reported TEKTURNA problem on Aug 08, 2007. Female patient was treated with TEKTURNA. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea decreased, . TEKTURNA dosage: 150 MG, QD, ORAL. Patient recovered.

Epanutinectable Side Effects Report #5464795-0
EPANUTINECTABLE problem was reported by a Pharmacist from UNITED KINGDOM on Aug 30, 2007. Male patient, 52 years of age, weighting 176.4 lb, was diagnosed with epilepsy, prophylaxis and was treated with EPANUTINECTABLE. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, blood urea decreased, convulsion, visual disturbance, . EPANUTINECTABLE dosage: unknown. During the same period patient was treated with PHENYTOIN, DALTEPARIN, PANTOPRAZOLE. Patient recovered.

Epanutinectable Side Effects Report #5425643-8
Pharmacist from UNITED KINGDOM reported EPANUTINECTABLE problem on Aug 14, 2007. Male patient, 52 years of age, was treated with EPANUTINECTABLE. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, blood urea decreased, convulsion, . EPANUTINECTABLE dosage: unknown. Patient recovered.

Bevacizumab Side Effects Report #5376412-9
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on June 22, 2007. Male patient, 41 years of age, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: anxiety, blood urea decreased, computerised tomogram abnormal, dysphagia, eructation, haematocrit decreased, haemoglobin decreased, hypovolaemia, lung neoplasm malignant, . BEVACIZUMAB dosage: 10 MG/KG, QOW. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5376412-9
Health Professional from UNITED STATES reported BEVACIZUMAB problem on June 22, 2007. Male patient, 41 years of age, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: anxiety, blood urea decreased, computerised tomogram abnormal, dysphagia, eructation, haematocrit decreased, haemoglobin decreased, hypovolaemia, lung neoplasm malignant, . BEVACIZUMAB dosage: 10 MG/KG, QOW. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5797780-X
REVLIMID problem was reported by a Physician from UNITED STATES on June 23, 2008. Male patient, 68 years of age, was diagnosed with 5q-syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, blood urea decreased, bone pain, bronchitis, bronchoalveolar lavage abnormal, bundle branch block, cardiac failure congestive, chest x-ray abnormal, chronic obstructive pulmonary disease, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL, 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with MOTRIN, ZESTRIL. Patient was hospitalized. Patient died on 03/08/2008.

Epivir Side Effects Report #5739967-8
Health Professional from UNITED STATES reported EPIVIR problem on May 13, 2008. Female patient, 33 years of age, weighting 163.1 lb, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea decreased, cerebrovascular accident, condition aggravated, neuropathy peripheral, . EPIVIR dosage: 150 MG BID PO. During the same period patient was treated with SUSTIVA, ZERIT, RETROVIR, VITAMIN. Patient was hospitalized. Patient died on 12/04/2007.

Zoladex Side Effects Report #5723598-X
ZOLADEX problem was reported by a Consumer or non-health professional from BRAZIL on Apr 23, 2008. Male patient, 80 years of age, weighting 138.9 lb, was diagnosed with prostate cancer recurrent, pollakiuria, anaemia and was treated with ZOLADEX. After drug was administered, patient experienced the following problems/side effects: blood creatinine decreased, blood urea decreased, decreased appetite, dizziness, labyrinthitis, nausea, pollakiuria, prostatic specific antigen increased, renal disorder, . ZOLADEX dosage: unknown. During the same period patient was treated with DOXAZOSIN MESYLATE, PROPATYLNITRATE, CILOSTAZOLE, SOMALGIN CARDIO, NORIPURUM, PAPAVERINE, TORLOS H. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5324954-4
Physician from UNITED STATES reported REVLIMID problem on Apr 27, 2007. Male patient, 89 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: amnesia, blood urea decreased, cognitive disorder, confusional state, delirium, . REVLIMID dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient recovered.


Acetaminophen Side Effects Report #5272293-2
ACETAMINOPHEN problem was reported by a Health Professional from JAPAN on Mar 14, 2007. Female patient, 32 years of age, was treated with ACETAMINOPHEN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood urea decreased, hepatic enzyme increased, hypokalaemia, hypophosphataemia, overdose, . ACETAMINOPHEN dosage: unknown. During the same period patient was treated with NARON. Patient recovered.

Tacrolimus Side Effects Report #5285385-9
Physician from JAPAN reported TACROLIMUS problem on Mar 13, 2007. Female patient, 50 years of age, weighting 119.0 lb, was diagnosed with myasthenia gravis, rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: angiopathy, blood urea decreased, cerebral infarction, folliculitis, hemiplegia, lacunar infarction, low density lipoprotein increased, nasopharyngitis, . TACROLIMUS dosage: 2 MG, UID/QD, ORAL. During the same period patient was treated with RHEUMATREX, MEDROL, MESTINON, ASPARA, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5536110-5
REVLIMID problem was reported by a Physician from UNITED STATES on Nov 26, 2007. Male patient, 82 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: anaemia, blood creatinine increased, blood urea decreased, blood urea increased, hypocalcaemia, leukopenia, neutrophil count decreased, thrombocytopenia, . REVLIMID dosage: 25 MG, DAILY, ORAL; 15 MG, DAYS 1-21, ORAL. During the same period patient was treated with DEXAMETHASONE, ASPIRIN, NORVASC, LIPITOR, ATENOLOL. Patient recovered.

Tacrolimus Side Effects Report #5385427-6
Physician from JAPAN reported TACROLIMUS problem on May 14, 2007. Female patient, 50 years of age, weighting 119.0 lb, was diagnosed with myasthenia gravis, rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood pressure increased, blood urea decreased, cerebral infarction, folliculitis, lacunar infarction, low density lipoprotein increased, nasopharyngitis, transient ischaemic attack, . TACROLIMUS dosage: 2 MG, UID/QD, ORAL. During the same period patient was treated with RHEUMATREX, MEDROL, MESTINON, ASPARA, ALOSITOLLET. Patient was hospitalized. Patient recovered.

Metronidazole Side Effects Report #5387162-7
METRONIDAZOLE problem was reported by a Health Professional from UNITED STATES on June 29, 2007. Female patient, 58 years of age, was diagnosed with vaginal infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: asthenia, blood lactate dehydrogenase increased, blood urea decreased, chest pain, chills, disseminated intravascular coagulation, haematocrit decreased, haematuria, haemoglobin decreased, . METRONIDAZOLE dosage: unknown. During the same period patient was treated with SERTRALINE, QUETIAPINE, LORAZEPAM, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.

Exenatide Side Effects Report #5414179-6
Consumer or non-health professional from UNITED STATES reported EXENATIDE problem on Apr 02, 2007. Male patient, 67 years of age, weighting 192.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood creatinine decreased, blood glucose increased, blood urea decreased, decreased appetite, nasopharyngitis, sinus congestion, tooth infection, weight decreased, . EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN, HUMALOG, LANTUS, GLIPIZIDE. Patient recovered.

Tacrolimus Side Effects Report #5385427-6
TACROLIMUS problem was reported by a Physician from JAPAN on May 14, 2007. Female patient, 50 years of age, weighting 119.0 lb, was diagnosed with myasthenia gravis, rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood pressure increased, blood urea decreased, cerebral infarction, folliculitis, lacunar infarction, low density lipoprotein increased, nasopharyngitis, transient ischaemic attack, . TACROLIMUS dosage: 2 MG, UID/QD, ORAL. During the same period patient was treated with RHEUMATREX, MEDROL, MESTINON, ASPARA, ALOSITOLLET. Patient was hospitalized. Patient recovered.

Metronidazole Side Effects Report #5387162-7
Health Professional from UNITED STATES reported METRONIDAZOLE problem on June 29, 2007. Female patient, 58 years of age, was diagnosed with vaginal infection and was treated with METRONIDAZOLE. After drug was administered, patient experienced the following problems/side effects: asthenia, blood lactate dehydrogenase increased, blood urea decreased, chest pain, chills, disseminated intravascular coagulation, haematocrit decreased, haematuria, haemoglobin decreased, . METRONIDAZOLE dosage: unknown. During the same period patient was treated with SERTRALINE, QUETIAPINE, LORAZEPAM, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.

Exenatide Side Effects Report #5414179-6
EXENATIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 02, 2007. Male patient, 67 years of age, weighting 192.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with EXENATIDE. After drug was administered, patient experienced the following problems/side effects: blood creatinine decreased, blood glucose increased, blood urea decreased, decreased appetite, nasopharyngitis, sinus congestion, tooth infection, weight decreased, . EXENATIDE dosage: unknown. During the same period patient was treated with METFORMIN, HUMALOG, LANTUS, GLIPIZIDE. Patient recovered.

Avastin Side Effects Report #5724152-6
Physician from UNITED KINGDOM reported AVASTIN problem on Apr 15, 2008. Male patient, weighting 156.5 lb, was diagnosed with colon cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, blood potassium decreased, blood urea decreased, blood urea increased, epistaxis, haematemesis, haematocrit decreased, haemoglobin decreased, oesophagitis, . AVASTIN dosage: 300 MG, Q2W. During the same period patient was treated with FLUOROURACIL, IRINOTECAN HYDROCHLORIDE, LEUCOVORIN CALCIUM, LAFUTIDINE, ZOPICLONE, CARBONATE, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Valtrex Side Effects Report #5344084-5
VALTREX problem was reported by a Physician from JAPAN on May 29, 2007. Female patient, 76 years of age, was diagnosed with herpes zoster and was treated with VALTREX. After drug was administered, patient experienced the following problems/side effects: asthenia, blood creatinine increased, blood urea decreased, dizziness, nervous system disorder, . VALTREX dosage: 500MG THREE TIMES PER DAY. During the same period patient was treated with HYDROXYZINE PAMOATE, ANDERM. Patient was hospitalized. Patient recovered.

Clozaril Side Effects Report #5326226-0
Consumer or non-health professional from UNITED STATES reported CLOZARIL problem on May 11, 2007. Male patient, 51 years of age, was diagnosed with schizophrenia and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, blood sodium decreased, blood urea decreased, eosinophil count decreased, granulocytopenia, leukopenia, lymphocyte count decreased, lymphopenia, white blood cell count decreased, . CLOZARIL dosage: 300 MG, QHS. During the same period patient was treated with HALDOL, COGENTIN, ASPIRIN, IBUPROFEN. Patient was hospitalized. Patient recovered.

Cap Side Effects Report #5326846-3
CAP VORINOSTAT problem was reported by a Consumer or non-health professional from SINGAPORE on Apr 24, 2007. Female patient, 51 years of age, was diagnosed with breast cancer metastatic and was treated with CAP VORINOSTAT. After drug was administered, patient experienced the following problems/side effects: ascites, blood creatinine increased, blood urea decreased, dehydration, disease progression, fatigue, heart rate increased, hypokalaemia, oral intake reduced, . CAP VORINOSTAT dosage: 400 MG/AM/PO. During the same period patient was treated with METOCLOPRAMIDE, MORPHINE, POTASSIUM CHLORIDE, CHLORIDE, TOLBUTAMIDE. Patient was hospitalized. Patient recovered.

Tacrolimus Side Effects Report #5337095-7
Physician from JAPAN reported TACROLIMUS problem on Apr 14, 2007. Female patient, 50 years of age, weighting 119.0 lb, was diagnosed with myasthenia gravis, rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: angiopathy, blood cholesterol increased, blood urea decreased, cerebral infarction, folliculitis, hemiplegia, low density lipoprotein increased, nasopharyngitis, . TACROLIMUS dosage: 2 MG, UID/QD, ORAL. During the same period patient was treated with RHEUMATREX, MEDROL, MESTINON, ASPARA, ALOSITOLLET. Patient was hospitalized. Patient recovered.

Remicade Side Effects Report #5343934-6
REMICADE problem was reported by a Pharmacist from UNITED STATES on May 31, 2007. Male patient, weighting 21.16 lb, was diagnosed with graft versus host disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, blood ph decreased, blood urea decreased, bloody discharge, dialysis, haemolysis, hypertension, oxygen saturation decreased, pulmonary oedema, . REMICADE dosage: 5MG/KG Q 7D X3 DOSES IV DRIP. During the same period patient was treated with TACROLIMUS, MYCOPHENOLATE MOFETIL, BECLOMETHASONE DIPROPIONATE, ESOMEPRAZOLE MAGNESIUM, FLUCONAZOLE, GENCICLOVIR, KEPPRA. Patient was hospitalized and became disabled. Patient recovered.

Byetta Side Effects Report #5364111-9
Consumer or non-health professional from UNITED STATES reported BYETTA problem on Jan 03, 2007. Male patient, 67 years of age, weighting 192.0 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: blood creatinine decreased, blood glucose increased, blood urea decreased, decreased appetite, sinus congestion, weight decreased, . BYETTA dosage: unknown. During the same period patient was treated with METFORMIN, HUMALOG, LANTUS, GLIPIZIDE, OVER THE COUNTER NASAL SPRAY. Patient recovered.

Temozolomide Side Effects Report #5315285-7
TEMOZOLOMIDE problem was reported by a Physician from UNITED STATES on Apr 20, 2007. Male patient, 61 years of age, weighting 194.0 lb, was diagnosed with glioblastoma multiforme and was treated with TEMOZOLOMIDE. After drug was administered, patient experienced the following problems/side effects: asthenia, blood sodium increased, blood urea decreased, blood urea increased, cellulitis, depression, fatigue, hemiparesis, hyperglycaemia, . TEMOZOLOMIDE dosage: unknown. Patient was hospitalized. Patient recovered.

Clozaril Side Effects Report #5262583-1
Physician from UNITED KINGDOM reported CLOZARIL problem on Feb 27, 2007. Male patient, 32 years of age, weighting 183.0 lb, was diagnosed with schizophrenia, schizoaffective disorder, agitation and was treated with CLOZARIL. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, blood pressure increased, blood urea decreased, body temperature increased, c-reactive protein increased, dyspnoea, electrocardiogram abnormal, haemoglobin decreased, neutrophil count increased, . CLOZARIL dosage: 50 MG, BID. During the same period patient was treated with DEPAKOTE, DIAMORPHINE, DIAZEPAM, PROMETHAZINE, VALPROATE. Patient was hospitalized and became disabled. Patient recovered.